Thomas Sarrade
YOU?
Author Swipe
View article: Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas
Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas Open
International audience
View article: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas
Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas Open
CNIL-MR0004 Number HDH434.
View article: Artificial Intelligence contouring in radiotherapy for organs-at-risk and lymph node areas
Artificial Intelligence contouring in radiotherapy for organs-at-risk and lymph node areas Open
Introduction: The delineation of organs-at-risk and lymph node areas is a crucial step in radiotherapy, but it is time-consuming and associated with substantial user-dependent variability in contouring. Artificial intelligence (AI) appears…
View article: Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors
Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors Open
Purpose Radiation-induced lung injury (RILI) is strongly associated with various clinical conditions and dosimetric parameters. Former studies have led to reducing radiotherapy (RT) doses to the lung and have favored the discontinuation of…
View article: CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data
CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data Open
This article describes the methodology used and provides a characterization of the study population in CANTO-RT (CANcer TOxicities RadioTherapy). CANTO (NCT01993498) is a prospective clinical cohort study including patients with stage I-II…